Results 11 to 20 of about 45,310 (260)
Post-marketing safety surveillance of Haemophilus influenzae Type b conjugate vaccine in children aged 3 months to 5 years in Jiangsu, China [PDF]
Human Vaccines & ImmunotherapeuticsThis study evaluates the post-marketing safety profile of a Haemophilus influenzae Type b (Hib) conjugate vaccine in children aged 3 months to 5 y in China.
Yuxuan Zhou +5 more
doaj +2 more sources
Development of MenFive®, an affordable pentavalent meningococcal conjugate vaccine (ACYWX) for Africa and beyond [PDF]
Human Vaccines & ImmunotherapeuticsWide use of the groundbreaking vaccine MenAfriVac® has eliminated serogroup A meningococcal meningitis in the African meningitis belt and paved the way for elimination of all meningococcal disease outbreaks with the development, licensure, and ...
Mark R. Alderson +7 more
doaj +2 more sources
PLoS ONE, 2013 BackgroundThe meningococcal serogroup A (MenA) polysaccharide conjugate vaccine used in Sub-Saharan Africa does not prevent disease caused by MenW or MenX strains, which also cause epidemics in the region.
Rolando Pajon +2 more
doaj +1 more source
Human Vaccines & ImmunotherapeuticsIn a previous phase 3 clinical trial, a 23-valent pneumococcal polysaccharide vaccine (PPV23) induced robust immune responses in participants aged 2 years and older.
Lili Huang +12 more
doaj +1 more source
Recommendation for use of the newly introduced pneumococcal protein conjugate vaccines in Korea [PDF]
Korean Journal of Pediatrics, 2011 Streptococcus pneumoniae remains a leading cause of invasive infections including bacteremia and meningitis, as well as mucosal infections such as otitis media and pneumonia among children and adults.
Eun Hwa Choi +9 more
doaj +1 more source
Expert Review of Vaccines, 2003 Conjugate vaccines in which the capsular polysaccharide of Haemophilus influenzae type b, common serotypes of Streptococcus pneumoniae and group C Neisseria meningitidis are covalently bound to a protein antigen to convert a T-cell-independent immune response into a T-cell-dependent response have proved highly effective in the prevention of invasive ...
openaire +2 more sources
Uptake of Pneumococcal Vaccines Among U.S. Adults After 2022 Update to Recommendations
AJPM FocusIntroduction: Updated recommendations for adult pneumococcal vaccination in the U.S. (publication date: January 27, 2022) incorporated 2 new vaccines (15- and 20-valent pneumococcal conjugate vaccines), removed 13-valent pneumococcal conjugate vaccine ...
Ahuva Averin, MPP +5 more
doaj +1 more source
Severe polyserositis induced by the 13-valent pneumococcal conjugate vaccine: a case report
Journal of Medical Case Reports, 2017 Background The United States Advisory Committee on Immunization Practices recommends administration of the 13-valent pneumococcal conjugate vaccine in series with the 23-valent pneumococcal polysaccharide vaccine for prevention of pneumonia in the ...
Pierre Tawfik +2 more
doaj +1 more source
Frontiers in Immunology, 2021 Passive immunization with specific egg yolk antibodies (immunoglobulin Y, IgY) is emerging as a promising alternative to antibiotics to control bacterial infections.
Ximin Zeng +7 more
doaj +1 more source
Trends and variations in the epidemiology of meningococcal disease in Kuwait 1987–2013
Journal of Infection and Public Health, 2015 Summary: The introduction of Haemophilus influenzae type b (Hib) conjugate vaccine and conjugate pneumococcal vaccine into routine childhood vaccination in Kuwait has resulted in the emergence of Neisseria meningitidis as the leading cause of invasive ...
Entesar H. Husain +2 more
doaj +1 more source